Localization and trafficking of α2-adrenergic receptor subtypes in cells and tissues

Pharmacology and Therapeutics

Volumn 84, Issue 2, 1999, Pages 193-205

  Saunders, Christine ^a   Limbird, Lee E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2AR subtypes; Adrenergic receptor; Localization; Trafficking

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BRIMONIDINE; CLONIDINE; DEXMEDETOMIDINE; GUANABENZ; GUANINE NUCLEOTIDE BINDING PROTEIN; IDAZOXAN; ISOPRENALINE; MIANSERIN; NORADRENALIN; OXYMETAZOLINE; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; RAUWOLSCINE; RECEPTOR SUBTYPE; YOHIMBINE; ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE;

CELL TRANSPORT; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; HUMAN; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CHEMISTRY; IN VITRO STUDY; PHYSIOLOGY;

ADRENERGIC AGONISTS; ANIMALS; CATECHOLAMINES; CELLS, CULTURED; HUMANS; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0032586029     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00032-7     Document Type: Review

References (128)

1. Ahlquist R.P. A study of adrenotropic receptors. Am J Physiol. 153:1948;586-600.
2. 2-adrenergic receptors in fibroblasts. J Biol Chem. 268:1993;22235-22238.
3. Aoki C., Go C.G., Venkatesan C., Kurose H. Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res. 650:1994;181-204.
4. Barak L.S., Tiberi M., Freedmen N.J., Kwatra M.M., Lefkowitz R.J., Caron M.G. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated β2-adrenergic receptor sequestration. J Biol Chem. 269:1994;2790-2795.
5. Berthelsen S., Pettinger W.A. A functional basis for classification of alpha-adrenergic receptors. Life Sci. 21:1977;595-606.
6. Bockman C.S., Jeffries W.B., Abel P.W. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther. 267:1993;1126-1133.
7. Bredt D.S. Sorting out genes that regulate epithelial and neuronal polarity. Cell. 94:1998;691-694.
8. Brown D.A., Crise B., Rose J.K. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science. 245:1989;1499-1501.
9. Bylund D.B. Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J. 6:1992;832-839.
10. Bylund D.B., Martinez J.R. Alpha 2-adrenergic receptors appear in rat salivary glands after reserpine treatment. Nature. 285:1980;229-230.
11. Cao T.T., Mays R.W., von Zastrow M. Regulated endocytosis of G protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits. J Biol Chem. 273:1998;24592-24602.
12. 2-adrenergic receptor subtypes by norepinephrine and buffers. Lanier S., Limbird L.E. Alpha-2 Adrenergic Receptors. Structure, Function, and Therapeutic Implications:1996;103-112 Gordon and Breach, London.
13. Chan Y.L. The role of norepinephrine in the regulation of fluid absorption in the rat proximal tubule. J Pharmacol Exp Ther. 215:1980;65-70.
14. Chang E.B., Field M., Miller R.J. Enterocyte alpha 2-adrenergic receptors. Yohimbine and p-aminoclonidine binding relative to ion transport Am J Physiol. 244:1983;G76-G82.
15. h is subtype specific and independent of its transglutaminase activity. J Biol Chem. 271:1996;32385-32391.
16. Chow M., Newman J.F.E., Filman D., Hogle J.M., Rowlands D.J., Brown F. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 327:1989;482-486.
17. Chuang D.M., Dillon-Carter O., Spain J.W., Laskowski M.B., Roth B.L., Coscia C.J. Detection and characterization of beta-adrenergic receptors and adenylate cyclase in coated vesicles isolated from bovine brain. J Neurosci. 6:1986;2578-2584.
18. 2-Adrenergic receptors regulate Na+-H+ exchange via a cAMP-dependent mechanism. Am J Physiol. 259:1990;F977-F985.
19. Clarke D., Garg L.C. Alpha 2 adrenergic receptors in inner medullary collecting duct cells of the rabbit kidney. J Pharmacol Exp Ther. 264:1993;879-888.
20. 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J Biol Chem. 266:1991;11025-11029.
21. Daunt D.A., Hurt C., Hein L., Kallio J., Feng F., Kobilka B.K. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol. 51:1997;711-720.
22. Davis C.G., Lehrman M.A., Russell D.W., Anderson R.G., Brown M.S., Goldstein J.L. The J.D. mutation in familial hypercholesterolemia. amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors Cell. 45:1986;15-24.
23. Davis C.G., van Driel I.R., Russel D.W., Brown M.S., Goldstein J.L. The low density lipoprotein receptor. Identification of amino acids in the cytoplasmic domain required for rapid endocytosis. J Biol Chem. 262:1987;4075-4082.
24. Denning G.A., Ostergaard L.S., Welsh M.J. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol. 118:1992;551-559.
25. Domino S.E., Repaske M.G., Bonner C.A., Kennedy M.E., Wilson A.L., Brandon S., Limbird L.E. Synthesis of a yohimbine-agarose matrix useful for large-scale and micropurification of multiple alpha 2-receptor subtypes. Methods Enzymol. 215:1992;181-200.
26. i-associated Gβγ-mediated activation of phospholipase C. Biochemistry. 36:1997;6415-6423.
27. Dotti C.G., Simons K. Polarized sorting of viral glycoproteins to the axon and dendrites of hippocampal neurons in culture. Cell. 62:1990;63-72.
28. Dotti C.G., Parton R.G., Simons K. Polarized sorting of glypiated proteins in hippocampal neurons. Nature. 349:1991;158-161.
29. Drubin D.G., Nelson W.J. Origins of cell polarity. Cell. 84:1996;335-344.
30. Eason M.G., Liggett S.B. Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. J Biol Chem. 267:1992;25473-25479.
31. 2A-adrenergic receptor. J Biol Chem. 271:1996;12826-12832.
32. 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation. Proc Natl Acad Sci USA. 91:1994;11178-11182.
33. Exton J.H. Cell signaling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases. Eur J Biochem. 243:1997;10-20. a.
34. Exton J.H. Regulation of phosphoinositide phospholipases by G-proteins. Adv Exp Med Biol. 400A:1997;3-8. b.
35. Faux M.C., Scott J.D. Molecular glue. kinase anchoring and scaffold proteins Cell. 85:1996;9-12.
36. Ferguson S.S.G., Barak L.S., Zhang J., Caron M.G. G protein-coupled receptor regulation. role of G protein-coupled receptor kinases and arrestins Can J Physiol Pharmacol. 74:1996;1095-1110.
37. Fish E.M., Molitoris B.A. Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med. 330:1994;1580-1588.
38. ras independent pathway. J Biol Chem. 270:1995;3491-3494.
39. Garvey W.T., Maianu L., Zhu J.-H., Brechtel-Hook G., Wallace P., Baron A. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest. 101:1998;2377-2386.
40. i down-regulation and heterologous desensitization in adipocytes after treatment with the alpha 2-agonist UK 14304. Biochem Pharmacol. 49:1995;785-790.
41. 2-adrenergic, muscarinic, and opiate receptors Mol Pharmacol. 43:1993;434-443.
42. Hansen S.H., Sandvig K., van Deurs B. Clathrin and HA2 adaptors. effects of potassium depletion, hypertonic medium, and cytosol acidification J Cell Biol. 121:1993;61-72.
43. Harden T.K., Cotton C.U., Waldo G.L., Lutton J.K., Perkins J.P. Catecholamine-induced alteration in sedimentation behavior of membrane bound beta-adrenergic receptors. Science. 210:1980;441-443.
44. Hausdorff W.P., Bouvier M., O'Dowd B.F., Irons G.P., Caron M.P., Lefkowitz R.J. Phosphorylation sites on two domains of the human β2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem. 264:1989;12657-12665.
45. Heck D.A., Bylund D.B. Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther. 282:1997;1219-1227.
46. Hieble J.P., Bondinell W.E., Ruffolo R.R. Jr. α- and β-adrenoceptors. From the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification J Med Chem. 38:1995;3415-3444.
47. Huang L., Wei Y.Y., Momose-Hotokezaka A., Dickey J., Okusa M.D. Alpha 2B-adrenergic receptors. immunolocalization and regulation by potassium depletion in rat kidney Am J Physiol. 270:1996;F1015-F1026.
48. Huang Y., Gil D.W., Vanscheeuwijck P., Stamer W.D., Regan J.W. Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Invest Ophthalmol Vis Sci. 36:1995;2729-2739.
49. Hunziker W., Harter C., Matter K., Mellman I. Basolateral sorting in MDCK cells requires a distinct cytoplasmic domain determinant. Cell. 66:1991;907-920.
50. 1-adrenergic receptor. II. Purification, characterization and reconstitution. J Biol Chem. 26:1990;18952-18960.
51. Innamorati G., Sadeghi H.M., Tran N.T., Birnbaumer M. A serine cluster prevents recycling of the V2 vasopressin receptor. Proc Natl Acad Sci USA. 95:1998;2222-2226.
52. Insel P.A. Adrenergic receptors, G proteins, and cell regulation. implications for aging research Exp Gerontol. 28:1993;341-348.
53. Insel P.A. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors - evolving concepts and clinical implications. N Engl J Med. 334:1996;580-585.
54. 2C2 adrenergic receptor is required for agonist-promoted phosphorylation and desensitization. Biochemistry. 34:1995;11946-11953.
55. 2A-adrenergic receptor. Biochemistry. 36:1997;8858-8863.
56. Jones C.J., DeFily D.V., Patterson J.L., Chilian W.M. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 87:1993;1264-1274.
57. Jones S.B., Leone S.L., Bylund D.B. Desensitization of the alpha-2 adrenergic receptor in HT29 and opossum kidney cell lines. J Pharmacol Exp Ther. 254:1990;294-300.
58. 2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol Pharmacol. 39:1991;239-245.
59. Keefer J.R., Limbird L.E. The alpha 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins. J Biol Chem. 268:1993;11340-11347.
60. 2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells. J Biol Chem. 269:1994;16425-16433.
61. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G protein coupling. J Biol Chem. 268:1993;8003-8011.
62. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 353:1991;43-48.
63. Kleuss C., Scherubl H., Hescheler J., Schultz G., Wittig B. Different beta-subunits determine G protein interaction with transmembrane receptors. Nature. 358:1992;424-426.
64. Kleuss C., Scherubl H., Hescheler J., Ewel C., Schultz G., Wittig B. Selectivity in signal transduction determined by γ subunits of heterotrimeric G proteins. Science. 259:1993;832-834.
65. 2-adrenergic receptors. delineation of domains involved in effector coupling and ligand binding specificity Science. 240:1988;1310-1316.
66. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G βγ-mediated signaling. J Biol Chem. 269:1994;6193-6197.
67. Krueger K.M., Daaka Y., Pitcher J.A., Lefkowitz R.J. The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem. 272:1997;5-8.
68. Kurose H., Lefkowitz R.J. Differential desensitization and phosphorylation of three cloned and transfected alpha2-adrenergic receptor subtypes. J Biol Chem. 269:1994;10093-10099.
69. Langer S.Z. Presynaptic regulation of catecholamine release. Br J Pharmacol. 60:1974;481-497.
70. Lanier S., Downing S., Duzic E., Homcy C.J. Isolation of rat genomic clones encoding subtypes of the alpha-2 adrenergic receptor. Identification of a unique receptor subtype. J Biol Chem. 266:1991;10470-10478.
71. Le Bivic A., Sambuy Y., Patzak A., Patil N., Chao M., Rodriguez-Boulan E. An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells. J Cell Biol. 115:1991;607-618.
72. 2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096.
73. 2A-adrenergic receptor by protein kinase C. Mol Pharmacol. 54:1998;44-49.
74. 2-adrenergic receptor regulation. Goldstein D.S., Eisenhofer G., McCarty R. Catecholamines. Bridging Basic Science with Clinical Medicine. 1998;438-442 Academic Press, San Diego.
75. Limbird L.E. Receptors linked to inhibition of adenylate cyclase. Additional signaling mechanisms FASEB J. 2:1988;2686-2695.
76. Lin F.T., Krueger K.M., Kendall H.E., Daaka Y., Fredericks Z.L., Pitcher J.A., Lefkowitz R.J. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem. 272:1997;31051-31057.
77. Lisanti M.P., Caras I.W., Davitz M.A., Rodriguez-Boulan E. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J Cell Biol. 109:1989;2145-2156.
78. Lockette W., Ghosch S., Farrow S., MacKenzie S., Baker S., Miles P., Schock A., Cadaret L. Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 8:1995;390-394.
79. MacDonald E., Kobilka B.K., Sheinin M. Gene targeting-homing in on α2-adrenoceptor subtype function. Trends Pharmacol Sci. 18:1997;211-219.
80. MacNulty E.E., McClue S.J., Carr I.C., Jess T., Wakelam M.J., Milligan G. Alpha 2-C10 adrenergic receptors expressed in rat 1 fibroblasts can regulate both adenylyl cyclase an phospholipase D-mediated hydrolysis of phosphatidylcholine by interacting with pertussis toxin-sensitive guanine nucleotide-binding proteins. J Biol Chem. 267:1992;2149-2156.
81. Matsushima Y., Akabane S., Kawamura J., Ito K. Distribution of alpha 1- and alpha 2-adrenoceptors in brush border and basolateral membranes from rat kidney cortical tubules. Jpn J Pharmacol. 45:1987;284-287.
82. Matter K., Mellman I. Mechanisms of cell polarity. Sorting and transport in epithelial cells Curr Opin Cell Biol. 6:1994;545-554.
83. McKernan R.M., Howard M.J., Motulsky H.J., Insel P.A. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Mol Pharmacol. 32:1987;258-265.
84. Muntz, K. H., Gilman, A. G., & Mumby, S. M. (1992). Distribution of endogenous G-protein subunits in the plasma membrane of cultured cells. Circulation 86, I-764.
85. Nicholas A.P., Pieribone V., Hökfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain. an in situ hybridization study J Comp Neurol. 328:1993;575-594.
86. Oksche A., Schülein R., Rutz C., Liebenhoff U., Dickson J., Müller H., Birnbaumer M., Rosenthal W. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus. analysis of expression, processing, and function Mol Pharmacol. 50:1996;820-828.
87. 1-adrenergic receptor that regulate agonist-promoted endocytosis. J Biol Chem. 270:1995;6482-6487.
88. Parton R.G., Simmons K., Dotti C.G. Axonal and dendritic endocytic pathways in cultured neurons. J Cell Biol. 119:1992;123-137.
89. Pettinger W.A., Umemura S., Smyth D.D., Jeffries W.B. Renal alpha 2-adrenoceptors and the adenylate cyclase-cAMP system. biochemical and physiological interactions Am J Physiol. 252:1987;F199-F208.
90. Pietrini G., Suh Y.J., Edelmann L., Rudnick G., Caplan M.J. The axonal γ-aminobutyric acid transporter GAT-1 is sorted to the apical membranes of polarized epithelial cells. J Biol Chem. 269:1994;4668-4674.
91. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol. 47:1995;666-676.
92. 2-adrenoceptor subtypes. Eur J Pharmacol. 244:1993;181-185.
93. Richman J.G., Regan J.W. Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am J Physiol. 274:1998;C654-C662.
94. Rodriguez-Boulan E., Powell S.K. Polarity of epithelial and neuronal cells. Annu Rev Cell Biol. 8:1992;395-427.
95. 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol. 372:1996;135-165.
96. Ruffolo R.R. Jr., Hieble J.P. α-Adrenoceptors. Pharmacol Ther. 61:1994;1-64.
97. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjoholm B., Macdonald E., Pelto-Huikko M., Leino T., Barsh G.S., Kobilka B.K., Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice. influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist Mol Pharmacol. 51:1997;36-46.
98. Saunders C., Limbird L.E. Disruption of microtubules reveals two independent apical targeting mechanisms for G-protein-coupled receptors in polarized renal epithelial cells. J Biol Chem. 272:1997;19035-19045.
99. Saunders C., Keefer J.R., Kennedy A.P., Wells J.N., Limbird L.E. Receptors coupled to pertussis toxin-sensitive G-proteins traffic to opposite surfaces in Madin-Darby canine kidney cells. A1 adenosine receptors achieve apical and alpha 2A adrenergic receptors achieve basolateral localization. J Biol Chem. 271:1996;995-1002.
100. Saunders C., Keefer J.R., Bonner C.A., Limbird L.E. Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals. J Biol Chem. 273:1998;24196-24206.
101. Schaak S., Cayla C., Blaise R., Quinchon F., Paris H. HepG2 and SK-N-MC. two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype J Pharmacol Exp Ther. 281:1997;983-991.
102. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., Fremeau R.T. Jr. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res. 21:1994;133-149.
103. Schöneberg T., Yun J., Wenkert D., Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J. 15:1996;1283-1291.
104. 2-adrenergic receptors is independent of endocytosis. J Biol Chem, in press.
105. Seuwen K., Magnaldo I., Kobilka B.K., Caron M.G., Regan J.W., Lefkowitz R.J., Pouyssegar J. Alpha 2-adrenergic agonists stimulate DNA synthesis in Chinese hamster lung fibroblasts transfected with a human alpha 2-adrenergic receptor gene. Cell Regul. 1:1990;445-451.
106. Stamer W.D., Huang Y., Seftor R.E., Svensson S.S., Snyder R.W., Regan J.W. Cultured human trabecular meshwork cells express functional alpha 2A adrenergic receptors. Invest Opthalmol Vis Sci. 34:1996;2803-2812.
107. o is a major growth cone protein subject to regulation by GAP-43. Nature. 344:1990;836-841.
108. Summers R.J. Renal alpha adrenoceptors. Fed Proc. 43:1984;2917-2922.
109. Sung C.-H., Schneider B.G., Agarwal N., Papermaster D.S., Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc Natl Acad. Sci USA. 88:1991;8840-8844.
110. Thomas J.M., Hoffman B.B. Agonist-induced down-regulation of muscarinic cholinergic and alpha 2-adrenergic receptors after inactivation of Ni by pertussis toxin. Endocrinology. 119:1986;1305-1314.
111. Toews M.L., Waldo G.L., Harden T.K., Perkins J.P. Relationship between an altered membrane form and a low affinity form of the beta-adrenergic receptor occurring during catecholamine-induced desensitization. Evidence for receptor internalization. J Biol Chem. 259:1984;11844-11850.
112. Tsukaguchi H., Matsubara H., Taketani S., Mori Y., Seido T., Inada M. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest. 96:1995;2043-2050.
113. Valet P., Senard J.M., Devedjian J.C., Planat V., Salomon R., Voisin T., Drean G., Couvineau A., Daviaud D., Denis C., Laburthe M., Paris H. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa. J Clin Invest. 91:1993;2049-2057.
114. Valet P., Pages C., Jeanneton O., Daviaud D., Barbe P., Record M., Saulnier-Blache J.S., Lafontan M. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest. 101:1998;1431-1438.
115. Verkade P., Simons K. Robert Feulgen Lecture 1997. Lipid microdomains and membrane trafficking in mammalian cells. Histochem Cell Biol. 108:1997;211-220.
116. von Zastrow M., Link R., Daunt D., Barsh G., Kobilka B. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem. 268:1993;763-766.
117. 2-adrenergic receptor i3c region Mol Pharmacol. 50:1996;351-358.
118. Wang R.X., Limbird L.E. Distribution of mRNA encoding three alpha 2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the alpha 2A subtype in apoptosis. Mol Pharmacol. 52:1997;1071-1080.
119. 2A AR-receptor gene in transgenic animals Neuroscience. 74:1996;199-218.
120. Wang S.Y., Pilkey D.T. Identification in islets of Langerhans of a new rat alpha 2-adrenergic receptor. Diabetes. 43:1994;127-136.
121. 2B adrenergic receptor. Mol Pharmacol. 38:1990;681-688.
122. Whistler J.L., von Zastrow M. Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci USA. 95:1998;9914-9919.
123. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda J., Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
124. Wilson A.L., Seibert K., Brandon S., Cragoe E.J. Jr., Limbird L.E. Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtype. Mol Pharmacol. 39:1991;481-486.
125. Wozniak M., Limbird L.E. The three alpha-2 adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney cells via different targeting mechanisms. J Biol Chem. 271:1996;5017-5024.
126. Wozniak M., Limbird L.E. Trafficking itineraries of G protein-coupled receptors in epithelial cells do not predict receptor localization in neurons. Brain Res. 780:1998;311-322.
127. Wozniak M., Keefer J.R., Saunders C., Limbird L.E. Differential targeting and retention of G protein-coupled receptors in polarized epithelial cells. J Recept Signal Transduct Res. 17:1997;373-383.
128. Zhang J., Ferguson S.S., Barak L.S., Aber M.J., Giros B., Lefkowitz R.J., Caron M.G. Molecular mechanisms of G protein-coupled receptor signaling. role of G protein-coupling receptor kinases and arrestins in receptor desensitization and resensitization Recept Channels. 5:1997;193-199.